Pilot Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma Non-resectable Intervention: Device: UNI-DEB Sponsor: Jeil Pharmaceutical Co., Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Clinical Trials | Hepatocellular Carcinoma | Liver Cancer | Research